Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial by Manjaly Thomas, Z, Satti, I, Marshall, J, Harris, S, Lopez Ramon, R, Hamidi, A, Minhinnick, A, Riste, M, Stockdale, L, Lawrie, A, Vermaak, S, Wilkie, M, Bettinson, H, McShane, H

Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study by Wilkie, M, Tanner, R, Wright, D, Lopez Ramon, R, Beglov, J, Riste, M, Marshall, JL, Harris, SA, Bettencourt, PJG, Hamidi, A, van Diemen, PM, Moss, P, Satti, I, Wyllie, D, McShane, H

A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults by Wilkie, M, Satti, I, Minhinnick, A, Harris, S, Riste, M, Ramon, R, Sheehan, S, Thomas, Z, Wright, D, Stockdale, L, Hamidi, A, O'Shea, M, Dwivedi, K, Behrens, H, Davenne, T, Morton, J, Vermaak, S, Lawrie, A, Moss, P, McShane, H

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults by Riste, M, Marshall, JL, Satti, I, Harris, SA, Wilkie, M, Lopez Ramon, R, Wright, D, Wittenberg, RE, Vermaak, S, Powell Doherty, R, Lawrie, A, Conlon, CP, Cosgrove, C, Gleeson, F, Lipman, M, Moss, P, Perrin, F, Dedicoat, M, Bettinson, H, McShane, H

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-... by Satti, I, Marshall, JL, Harris, SA, Wittenberg, R, Tanner, R, Lopez Ramon, R, Wilkie, M, Ramos Lopez, F, Riste, M, Wright, D, Peralta Alvarez, MP, Williams, N, Morrison, H, Stylianou, E, Folegatti, P, Jenkin, D, Vermaak, S, Rask, L, Cabrera Puig, I, Powell Doherty, R, Lawrie, A, Moss, P, Hinks, T, Bettinson, H, McShane, H